What GLP-1s actually do
GLP-1 medications are the most-discussed class of drugs in diabetes care right now, and most of the headlines are about weight loss. The diabetes story is older and, in some ways, more interesting.
GLP-1s mimic a gut hormone your body already makes after meals. They lower blood sugar, slow digestion, and reduce appetite — three different effects from one mechanism.
GLP-1 stands for glucagon-like peptide-1. It's a hormone the gut releases after you eat. It tells the pancreas to make more insulin (when blood sugar is high), tells the liver to make less glucose, slows the rate at which the stomach empties, and signals the brain that you're full.
The medications in this class — semaglutide, liraglutide, dulaglutide, tirzepatide — are engineered versions of that hormone that last days instead of minutes. Most are weekly injections. A daily oral version of semaglutide also exists.
For people with Type 2 diabetes, the blood-sugar effect is significant. A1C drops of 1–2 points are typical. The weight loss — often 10–15% of body weight or more — is a side effect of the appetite and digestion changes, not a separate mechanism.
GLP-1s also have cardiovascular benefits that go beyond glucose control. Multiple large trials have shown reduced rates of heart attack, stroke, and cardiovascular death in people with Type 2 diabetes who have existing heart disease.
What this means for you
If you or your parent has Type 2 diabetes and your doctor mentions a GLP-1, the conversation is about more than sugar control. It's about a class of medication that touches metabolism, weight, and heart risk together.
Has a doctor ever brought up GLP-1s with you or someone in your family? What was your first question?